Anaphylaxis after low dose intravenous vitamin K

Journal of Emergency Medicine

Volumn 24, Issue 2, 2003, Pages 169-172

  Wjasow, Christina ^a   McNamara, Robert ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Anaphylaxis; Anticoagulation; Phytonadione; Vitamin K; Warfarin

Indexed keywords

ADRENALIN; DIPHENHYDRAMINE; METHYLPREDNISOLONE SODIUM SUCCINATE; VITAMIN K GROUP; WARFARIN;

ABNORMAL RESPIRATORY SOUND; AGED; ANAMNESIS; ANAPHYLAXIS; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG OVERDOSE; EDEMA; ELECTROCARDIOGRAM; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART AUSCULTATION; HEART BEAT; HUMAN; INTUBATION; LABORATORY TEST; LONG TERM CARE; MEDICAL EXAMINATION; OUTPATIENT DEPARTMENT; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; PRURITUS; RESPIRATORY ARREST; RESUSCITATION; WARFARIN OVER ANTICOAGULATION;

EID: 0037328808     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(02)00720-5     Document Type: Article

References (19)

1. Fifth ACCP consensus conference on antithrombotic therapy. Chest. 114:1998;445S-769S.
2. Sixth ACCP consensus conference on antithrombotic therapy. Chest. 119:2001;225-385.
3. Lefrere J.J., Girot R. Acute cardiovascular collapse during intravenous vitamin K1 injection. (letter) Thromb Haemost. 58:1987;790.
4. Songy K.A., Layon A.J. Vitamin K-induced cardiovascular collapse. J Clin Anesth. 9:1997;514-519.
5. Barash P., Kitahata L.M., Mandel S. Acute cardiovascular collapse after intravenous phytonadione. Anesth Analg. 55:1976;304-306.
6. De la Rubia J., Grau E., Montserrat I., Zuazu I., Paya A. Anaphylactic shock and vitamin K1. (letter) Ann Intern Med. 110:1989;943.
7. Martinez-Abad M., Delgado F. Vitamin K1 and anaphylactic shock. (letter) Ann Pharmacother. 25:1991;871-872.
8. Brophy M.T., Fiore L.D., Deykin D. Low-dose vitamin K therapy in excessively anticoagulated patients a dose-finding study . J Thromb Thrombolysis. 4:1997;289-292.
9. Arky R. (medical consultant). Physician's desk reference. (54th edn.): 2000;Medical Economics Company, Inc, Montvale, NJ. 1746-7.
10. Hirsh J., Dalen J.E., Deykin D., Poller L., Bussey H. Oral anticoagulants mechanism of action, clinical effectiveness, and optimal therapeutic range . Chest. 108:1995;231S-245S.
11. Crowther M.A., Donovan D., Harrison L., McGinnis J., Ginsberg J. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost. 79:1998;1116.
12. Weibert R.T., Le D.T., Kayser S.R., Rapaport S.I. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med. 125:1997;959-962.
13. Raj G., Kumar R., McKinney W.P. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 159:1999;2721-2724.
14. Whitling A.M., Bussey H.I., Lyons R.M. Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. Arch Intern Med. 158:1998;2136-2140.
15. Byrd D.C., Stephens M.A., Hamann G.L., Dorko C. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio. Am J Health Syst Pharm. 56:1999;2312-2315.
16. Nee R., Doppenschmidt D., Donovan D.J., Andrews T.C. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol. 83:1999;286-288.
17. Jahnchen E., Meinertz T., Gilfrich H.G., et al. Enhanced elimination of warfarin during treatment with cholestyramine. Br J Clin Pharmacol. 5:1978;437-440.
18. Renowden S., Westmoreland D., White P., Routledge P.A. Oral cholestyramine increases elimination of warfarin after overdose. Br Med J. 291:1985;813-814.
19. Roberge R.J., Rao P., Miske G.R., Riley T.J. Diarrhea-associated over-anticoagulation in a patient taking warfarin therapeutic role of cholestyramine . Vet Hum Toxicol. 42:2000;351-353.